SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Directorate Change

12 Dec 2023 07:00

RNS Number : 4670W
Accsys Technologies PLC
12 December 2023
 

AIM: AXS

Euronext Amsterdam: AXS

 

12 December 2023

 

Accsys Technologies PLC

("Accsys" or the "Company")

 

Directorate Appointments

 

Accsys, the fast-growing company that enhances the natural properties of wood to make high performance and sustainable building products, is pleased to announce the following appointments to its Board of Directors.

 

Appointment of Non-Executive Chair of Accsys

 

Further to the announcement on 12 September 2023, Accsys announces that the Board has appointed Trudy Schoolenberg as permanent Non-Executive Chair of Accsys after due process, including consultation with shareholders. Beyond her extensive experience with the Accsys business over the past five years, her appointment as Chair will contribute further stability and continuity to the Board. Trudy will also be appointed Chair of the Nomination Committee. Both her appointments will be effective from 12 December 2023.

 

Trudy was announced Interim Chair on 12 September 2023 having joined the Accsys Board as a Senior Independent Director in April 2018. Trudy has almost 30 years of experience working for blue-chip companies in the chemicals, engineering and high-performance product sectors. She spent over 20 years with Royal Dutch Shell where she led in R&D, operations and business strategy. She continued her career leading R&D in Wartsila, a blue-chip Finland based engineering company. Later she moved to AKZO Nobel decorative paints, where she was global Director for R&D, Manufacturing and Supply Chain. Trudy has over 10 years of experience as a Non-Executive Director for UK plc businesses, including roles as Senior Independent Director at Spirax Sarco Engineering plc, Elementis plc and TI Fluid Systems plc. 

 

Appointment of Edwin Bouwman

 

In addition, Accsys announces the appointment of Edwin Bouwman as a Non-Executive Director with effect from 12 December 2023. Edwin has been appointed by Teslin Participaties Coöperatief U.A. and "De Engh" B.V. under the terms of a Relationship Agreement dated 21 November 2023 and he will consequently be classified as non-independent. Edwin will also be a member of the Audit and Remuneration Committees.

 

Edwin brings over 30 years of experience in the energy and building materials industry and has held executive roles at both public and private multinational companies, including Royal Dutch Shell, Roto Smeets NV, CRH Plc and SHV Energy. During his career Edwin has established a track record of successful business transformation, delivering both organic and acquisitive growth strategies to enable substantial portfolio performance improvement.

 

Edwin currently serves as Non-Executive Director of Intergamma Coöperatief U.A where he is Chair of the Risk and Audit committee, and CliniClowns where he is Chair of the charity's Audit Committee.

 

Trudy Schoolenberg, Chair of Accsys, commented:

 

"I am delighted to have been appointed as Chair of Accsys. I am also pleased to welcome Edwin to the Board and we look forward to benefitting from his highly relevant experience. As I look ahead I believe Accsys is a business with tremendous opportunity, able to navigate the near-term market challenges and capable of meeting its significant potential. I look forward to supporting our CEO, Dr. Jelena Arsic van Os and the wider team in my role as Chair."

 

Dr. Jelena Arsic van Os, Chief Executive Officer of Accsys, added:

 

"I am very pleased with the appointments of Trudy Schoolenberg as Chair and Edwin Bouwman as Non-Executive Director given their strong industry knowledge. I am confident that the Accsys Board will benefit greatly from their sector experience and background."

 

The following information is disclosed in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies in relation to Edwin Bouwman's appointment to the Board as Non-Executive Director:

Full name: Edwin Henricus Odette Maria Bouwman

Age: 56 years

Current Directorships: Intergamma Coöperatief U.A., Stichting CliniClowns Nederland, Badhuis Holding B.V., Badhuis Management Services B.V.

 

Directorships held in the past five years: CRH Nederland B.V., Calor Group Limited, Liquigas S.p.A., SHK Grundstucks GmbH, CRH Deutschland GmbH, CRH Grundbesitz GmbH.

 

There are no other matters in relation to the appointment of Edwin Bouwman which are required to be disclosed in accordance with the AIM Rules for Companies.

 

Edwin Bouwman holds no shares in Accsys.

--ENDS---

For further information, please contact:

Accsys Technologies PLC Investor Relations

ir@accsysplc.com

Numis Securities (London) Oliver Hardy (NOMAD), Ben Stoop

+44 (0) 20 7260 1000

ABN AMRO Bank N.V. (Amsterdam) Julie Wakkie, Diederik Berend

+31 20 628 5789

FTI Consulting (UK) Matthew O'Keeffe, Alex Le May

+44 (0) 20 3727 1340 

Communications (NL)

Clemens Sassen, Tessa Nelissen, Huijskens Sassen

 

+31 (0) 20 68 55 955

 

 

 

 

 

Notes to editors:

 

Accsys (Accsys Technologies PLC) is a fast-growing business with a purpose: changing wood to change the world. The Company combines chemistry, technology and ingenuity to make high performance wood products that are extremely durable and stable, opening new opportunities for the built environment and giving the world a choice to build sustainably.

Accsys transforms fast-growing, certified sustainable wood into building materials with characteristics that match or better those of man-made, intensely resource-depleting and heavily carbon-polluting alternatives. 

The Company's primary focus is on the production of Accoya wood and Tricoya wood elements, as well as technology licensing via its subsidiaries Titan Wood Limited and Tricoya Technologies Limited. Accsys has its head office in London, UK, production operations in Arnhem, the Netherlands, an American office in Dallas, Texas, and is constructing the world's first Tricoya plant in Hull, UK.

Accsys is committed to a more sustainable world and uses abundantly available wood sources that are certified as sustainable. With our business model already aligned with several UN Sustainable Development Goals, Accsys is currently working on identifying further strategic ESG priorities to have an even greater positive impact on the world.

Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'.

More information about Accsys can be found at www.accsysplc.com 

Accoya wood is a sustainable, durable and stable solid wood product with exceptional performance, finish and sustainability. Accsys' proprietary acetylation process makes the wood more dimensionally stable and, because it is no longer easily digestible, extremely durable. Produced from certified (e.g. FSC®) sustainable sources, Accoya wood has many environmental credentials and ecolabels, and is one of very few building materials to be Cradle to Cradle Certified? at the Gold level, with a Platinum rating for Material Health, confirming that no harmful or toxic additives or chemicals are present to leach out into the environment.

With an up to 50-year warranty and 70+ year service life, the combination of sustainability, dimensional stability, durability and retained strength means that Accoya wood offers a wealth of new opportunities to architects, designers, specifiers, manufacturers and homeowners. These benefits result in lower maintenance and total cost of ownership while also offering significant sustainability benefits. For more information about Accoya wood, visit www.accoya.com.

Tricoya wood elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles for use in the fabrication of panel products such as medium density fibreboard (MDF) and particle-board.

Panel products made with Tricoya wood elements are truly durable and stable enough for use outdoors and in wet environments. Combining the sustainability, durability and stability from our acetylation process with the ease of use and quality finish of wood panel products, the enhanced durability and dimensional stability opens new opportunities for the use of these products, making them suitable in applications and environments that previously required solid wood, synthetic or unsustainable materials.

Tricoya wood elements have been lauded as the first major innovation in the wood composites industry in more than 30 years. For more information about Tricoya wood elements, visit www.tricoya.com.

Wood acetylation is a process which increases the naturally occurring acetyl content of wood, thereby changing its physical properties. When carried out to a sufficient degree throughout the wood, as with Accsys' proprietary process, it significantly reduces the ability of the wood to absorb water without adding any toxic or harmful compounds, elements or substances that were not already present in the wood. This makes it much more dimensionally stable and, because it is no longer easily digestible to most organisms, extremely durable.

'Accsys' and 'Accsys Technologies' are trading names of Titan Wood Limited ("TWL"), a wholly-owned subsidiary of Accsys Technologies PLC. Accoya, Tricoya and the Trimarque Device are registered trademarks owned by TWL and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya brand.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZMMZVZRGFZG
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
2nd Sep 20245:00 pmRNSTotal Voting Rights
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.